36
Participants
Start Date
March 13, 2017
Primary Completion Date
May 23, 2022
Study Completion Date
April 13, 2023
Laboratory Biomarker Analysis
Correlative studies
Nelfinavir Mesylate
Given PO
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx
Emory University/Grady Hospital, Atlanta
University of Miami, Miami
Ohio State University, Columbus
Washington University School of Medicine, St Louis
Baylor College of Medicine, Houston
Benaroya Research Institute at Virginia Mason Medical Center, Seattle
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Beth Israel Deaconess Medical Center, Boston
African Cancer Institute, Stellenbosch University, Cape Town
Uganda Cancer Institute, Kampala
National Cancer Institute (NCI)
NIH
The Emmes Company, LLC
INDUSTRY
University of Arkansas
OTHER
University of California, Los Angeles
OTHER
AIDS and Cancer Specimen Resource
OTHER
Montefiore Medical Center
OTHER
AIDS Malignancy Consortium
NETWORK